共 20 条
[1]
Muller RH(2000)Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art Eur J Pharm Biopharm 50 161-177
[2]
Mader K(2000)Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin Eur J Pharm Biopharm 49 211-218
[3]
Gohla S(2002)Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv Drug Deliv Rev 54 S131-S155
[4]
Jenning V(2000)An investigation into the use of stepwise DSC as a means of detecting drug-excipient incompatibility Int J Pharm 199 141-150
[5]
Gysler A(1999)Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase Eur J Pharm Biopharm 47 125-132
[6]
Schafer-Korting M(2003)The production and characteristics of solid lipid nanoparticles (SLNs) Biomaterials 24 1781-1785
[7]
Gohla S(undefined)undefined undefined undefined undefined-undefined
[8]
Muller RH(undefined)undefined undefined undefined undefined-undefined
[9]
Radtke M(undefined)undefined undefined undefined undefined-undefined
[10]
Wissing SA(undefined)undefined undefined undefined undefined-undefined